130 related articles for article (PubMed ID: 1645562)
1. Differences in vascular response between primary and transplanted tumours.
Field SB; Needham S; Burney IA; Maxwell RJ; Coggle JE; Griffiths JR
Br J Cancer; 1991 May; 63(5):723-6. PubMed ID: 1645562
[TBL] [Abstract][Full Text] [Related]
2. The energy metabolism of RIF-1 tumours following hydralazine.
Bhujwalla ZM; Tozer GM; Field SB; Maxwell RJ; Griffiths JR
Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156
[TBL] [Abstract][Full Text] [Related]
3. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.
Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC
Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours.
Horsman MR; Nordsmark M; Høyer M; Overgaard J
Br J Cancer; 1995 Dec; 72(6):1474-8. PubMed ID: 8519662
[TBL] [Abstract][Full Text] [Related]
5. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK
Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606
[TBL] [Abstract][Full Text] [Related]
6. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.
Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ
Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001
[TBL] [Abstract][Full Text] [Related]
7. Are transplanted tumours suitable as models for studies on vasculature?
Field SB; Burney IA; Needham S; Maxwell RJ; Coggle J; Griffiths JR
Int J Radiat Biol; 1991; 60(1-2):255-60. PubMed ID: 1677981
[No Abstract] [Full Text] [Related]
8. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.
Bhujwalla ZM; Tozer GM; Field SB; Proctor E; Busza A; Williams SR
NMR Biomed; 1990 Aug; 3(4):178-83. PubMed ID: 2206850
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
Nordsmark M; Maxwell RJ; Wood PJ; Stratford IJ; Adams GE; Overgaard J; Horsman MR
Br J Cancer Suppl; 1996 Jul; 27():S232-5. PubMed ID: 8763887
[TBL] [Abstract][Full Text] [Related]
10. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts.
Guichard M; Lespinasse F; Trotter M; Durand R; Chaplin D
Radiother Oncol; 1991 Feb; 20(2):117-23. PubMed ID: 2031087
[TBL] [Abstract][Full Text] [Related]
11. From hydralazine to CGRP to man?
Field SB; Burney IA; Needham S; Maxwell RJ; Griffiths JR
Int J Hyperthermia; 1994; 10(3):451-5. PubMed ID: 7930813
[TBL] [Abstract][Full Text] [Related]
12. Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
Burney IA; Maxwell RJ; Field SB; McCoy CL; Griffiths JR
Acta Oncol; 1995; 34(3):367-71. PubMed ID: 7779425
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study.
Dunn JF; Frostick S; Adams GE; Stratford IJ; Howells N; Hogan G; Radda GK
FEBS Lett; 1989 Jun; 249(2):343-7. PubMed ID: 2737292
[TBL] [Abstract][Full Text] [Related]
14. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor.
Constantinidis I; Gamcsik MP
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):143-9. PubMed ID: 7642412
[TBL] [Abstract][Full Text] [Related]
15. Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.
Fenton BM
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):799-808. PubMed ID: 11172963
[TBL] [Abstract][Full Text] [Related]
16. Nonglycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy.
Hwang YY; Kim SG; Evelhoch JL; Ackerman JJ
Cancer Res; 1992 Mar; 52(5):1259-66. PubMed ID: 1737388
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydralazine on blood flow, oxygenation, and interstitial fluid pressure in subcutaneous tumors.
Jarm T; Podobnik B; Sersa G; Miklavcic D
Adv Exp Med Biol; 2003; 510():25-9. PubMed ID: 12580400
[No Abstract] [Full Text] [Related]
18. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
Thomas C; Counsell C; Wood P; Adams GE
J Natl Cancer Inst; 1992 Feb; 84(3):174-80. PubMed ID: 1542128
[TBL] [Abstract][Full Text] [Related]
19. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
Horsman MR; Christensen KL; Overgaard J
Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
